To elicit whether tumor-specific reduction of NORE1 expression is caused by the aberrant promoter hypermethylation, the methylation status of 31 CpG sites located within the proximal region of the NORE1A promoter was characterized (Figure 5A and 5B). This evidence concerns the gene RASSF5 and neoplasm.